Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Seelos Therapeutics Inc (SEEL)

Seelos Therapeutics Inc (SEEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 426,642
  • Shares Outstanding, K 78,283
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,100 K
  • 60-Month Beta 2.94
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 115.56
Trade SEEL with:

Options Overview

Details
  • Implied Volatility 139.71%
  • Historical Volatility 125.82%
  • IV Percentile 3%
  • IV Rank 0.00%
  • IV High 352.41% on 03/04/21
  • IV Low 139.71% on 04/14/21
  • Put/Call Vol Ratio 0.27
  • Today's Volume 3,630
  • Volume Avg (30-Day) 3,819
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 31,520
  • Open Int (30-Day) 21,791

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.10
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +35.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.61 +33.52%
on 03/25/21
6.16 -21.75%
on 04/07/21
+0.07 (+1.47%)
since 03/12/21
3-Month
1.37 +251.82%
on 01/15/21
6.16 -21.75%
on 04/07/21
+3.38 (+234.72%)
since 01/14/21
52-Week
0.45 +971.11%
on 04/21/20
6.16 -21.75%
on 04/07/21
+4.31 (+835.92%)
since 04/14/20

Most Recent Stories

More News
Biotech Companies Driving Psychedelics Industry Forward with Key Research

, /PRNewswire/ -- As an urgent public mental health crisis forces research institutions and governments to seriously examine unconventional mental health solutions, psychedelic assisted therapies are...

CMPS : 35.95 (-1.15%)
MYCOF : 0.2671 (+1.40%)
NUMI.VN : 0.950 (-1.04%)
LKYSF : 0.7584 (+1.11%)
MINE : 0.0042 (-2.33%)
SEEL : 4.82 (-2.23%)
Mainstream Mental Health is Quickly Embracing Psychedelic Drug Therapies

These days, we can make a very strong case for mind-altering treatments for mental health. Not ...

SEEL : 4.82 (-2.23%)
CLXPF : 1.4600 (-1.35%)
MMEDF : 2.4300 (-3.57%)
TRYP.CN : 0.670 (+1.52%)
SILO.CN : 0.230 (+2.22%)
Do Options Traders Know Something About Seelos (SEEL) Stock We Don't?

Investors need to pay close attention to Seelos (SEEL) stock based on the movements in the options market lately.

SEEL : 4.82 (-2.23%)
Thinking about buying stock in Hyliion Holdings, BlackBerry, GT Biopharma, Seelos Therapeutics, or Oncternal Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HYLN, BB, GTBP, SEEL, and ONCT.

GTBP : 9.63 (+0.63%)
ONCT : 6.26 (-2.64%)
SEEL : 4.82 (-2.23%)
BB : 9.00 (-1.10%)
HYLN : 9.58 (-3.52%)
Thinking about buying stock in Phunware, Broadwind, Seelos Therapeutics, Golden Nugget Online Gaming, or Heron Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PHUN, BWEN, SEEL, GNOG, and HRTX.

GNOG : 15.57 (unch)
PHUN : 1.7100 (unch)
SEEL : 4.82 (-2.23%)
BWEN : 5.30 (-1.30%)
HRTX : 17.27 (+3.66%)
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.

, /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system (CNS) disorders and rare diseases,...

ATR : 145.81 (-0.36%)
SEEL : 4.82 (-2.23%)
Thinking about buying stock in Biocept, AbCellera Biologics, Novan, Seelos Therapeutics, or SRAX?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BIOC, ABCL, NOVN, SEEL, and SRAX.

ABCL : 28.25 (-0.04%)
NOVN : 1.2100 (-9.02%)
SEEL : 4.82 (-2.23%)
BIOC : 4.51 (+2.27%)
SRAX : 4.52 (-4.44%)
Thinking about buying stock in Orchard Therapeutics, Salarius Pharmaceuticals, Seelos Therapeutics, Evolus, or ENDRA Life Sciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ORTX, SLRX, SEEL, EOLS, and NDRA.

EOLS : 11.72 (+0.51%)
ORTX : 6.46 (-3.00%)
SEEL : 4.82 (-2.23%)
SLRX : 1.3000 (+2.36%)
NDRA : 2.28 (-3.39%)
Is Seelos Therapeutics a Good Biotech Stock to Add to Your Portfolio?

Biopharmaceutical company Seelos Therapeutics (SEEL), which focuses on developing treatments for central nervous system and respiratory disorders, has a history of share price weakness. However, does the...

SEEL : 4.82 (-2.23%)
The Race to Prove Psychedelics Can Help Resolve Mental Health Issues Has Just Begun

The psychedelics story is gaining momentum, as NeonMind Biosciences (CSE:NEON) (OTC:NMDBF), Lobe ...

LOBE.CN : 0.150 (-3.23%)
GTSIF : 0.1230 (-0.73%)
MYCOF : 0.2671 (+1.40%)
AIKI : 0.9609 (+1.64%)
SEEL : 4.82 (-2.23%)
NMDBF : 0.1800 (unch)
MYCO.CN : 0.400 (-6.98%)
NEON.CN : 0.220 (-2.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Seelos Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on the development and advancement of novel therapeutics to address unmet medical needs for central nervous system disorders. The company's product pipeline consists of SLS-002, SLS-006, SLS-008, SLS-010 and SLS-012 which...

See More

Key Turning Points

3rd Resistance Point 5.53
2nd Resistance Point 5.37
1st Resistance Point 5.09
Last Price 4.82
1st Support Level 4.65
2nd Support Level 4.49
3rd Support Level 4.21

See More

52-Week High 6.16
Last Price 4.82
Fibonacci 61.8% 3.98
Fibonacci 50% 3.30
Fibonacci 38.2% 2.63
52-Week Low 0.45

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar